← Themes
Theme · 61 callers · 17d avg lead
Biotech (oncology / dermatology / rare disease)
COOL17% runningNames in this theme
23 totalSort by
| Ticker | Price | Day | Callers | Core |
|---|---|---|---|---|
| $ARTV | $5.23 | -2.61% | 12 | core |
| $MANE | $63.49 | +2.54% | 12 | core |
| $NKTR | $72.96 | -1.86% | 8 | core |
| $NTLA | $12.81 | -2.29% | 8 | core |
| $SNSE | $29.97 | -8.57% | 8 | core |
| $STRO | $23.57 | +10.50% | 8 | core |
| $BSX | $68.15 | -2.00% | 6 | — |
| $CVS | $72.80 | +2.12% | 6 | — |
| $ABVX | $110.17 | -4.55% | 5 | core |
| $BBIO | $68.53 | -1.54% | 5 | — |
| $RVMD | $95.52 | -1.15% | 5 | — |
| $AXSM | $158.75 | +1.22% | 4 | — |
| $SNY | $45.14 | +0.83% | 4 | — |
| $ABCL | $3.31 | -1.78% | 4 | — |
| $INSM | $139.14 | -3.36% | 4 | — |
| $ARTL | $5.79 | -24.41% | 3 | core |
| $MLEC | $6.77 | -8.39% | 3 | core |
| $VCX | $314.99 | +64.22% | 3 | core |
| $HROW | $35.20 | +3.53% | 2 | core |
| $APGE | $73.00 | -7.87% | 2 | core |
| $SNDX | $24.02 | -0.29% | 2 | — |
| $LONA | $9.02 | -3.74% | 0 | core |
| $RLYB | $8.67 | -4.83% | 0 | core |
Callers covering this theme
@911_TruthNow@A_May_MD@AmericanBanking@ArtivaBio@BPharmCatalyst@BioValues@Biotech2k1@BiotechTV@BradFinntrader@BruceMarti1540@BryceChandlerE8@CHItrader@CorleoneDon77@El0ns15ThChild@Frenchie_@GoldnGuitars@Gregmass86@JacobPlieth@JeffTheOmega1@JonahLupton@KarenWongAU@LTbioinvestor@Lee_Shikoh@LuoshengPeng@Lycanbull@MarcJacksonLA@Optimalinvestme@OzmosiHealth@ProfitGrand@RSkeers@SWGoldReport@SWReports@Speculator_io@SutroBio@VertiCallAlgo@a_may_md@ahinpet111@ainvest_vision@aleabitoreddit@arielsbdar@bioscifiryan@broadhead_trade@cluelessbio@dhovekamp42@gemini_edge@j_fry24@jbdotdotdot@miya_0135@mmmbullbear@monaco_biotech@n_hatami@pythoninvestor@realskyfreejr@ripster47@steve2bacon@tenet_research@tiffinyfawcett@tradingsssss@whalewisdom@youngallien@zohmbastic
Recent calls in this theme
Mar 18, 2026
“Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting $MANE stocktitan.net/news/MANE/ver…”View original tweet ↗
Mar 18, 2026
“$MANE Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting More Info: pryzm.ozmosi.com/product/331…”View original tweet ↗
Mar 18, 2026
“$MANE Veradermicsが2026年AAD年次総会で3件の抄録を発表予定。パターン脱毛症に関するVDPHL01のデータと患者経験研究を含む。”View original tweet ↗
Mar 18, 2026
“$MANE - Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting”View original tweet ↗
Mar 15, 2026
“$mane Minox is an antiandrogen just like every other drug that works for androg alop and will effect your erection quality and sex drive. Btw if applying minox topically all over your head instead of just some areas, as you should, more of it goes systemic than 2.5 mg oral. 1/”View original tweet ↗
Mar 15, 2026
“I sold and went big in $MANE .. I like tower $TSEM better. $MANE VERADERMICS INC FilledBuy186Limit $54.30Day $54.066”View original tweet ↗
Sep 3, 2024
“New SC 13D/A from RA CAPITAL MANAGEMENT, L.P. concerning $ARTV . See details at whalewisdom.com/filing/ra-ca…”View original tweet ↗
Sep 2, 2024
“I'd wait for lockup to expire before making a move, but $ARTV 's pipeline value does look promising.”View original tweet ↗
Sep 1, 2024
“$ARTV has a pipeline of alloNK cell programs for CD19 in Autoimmune and Oncology.”View original tweet ↗
Aug 29, 2024
“- $ARTV - Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - globenewswire.com/news-relea…”View original tweet ↗
Aug 29, 2024
“Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights investors.artivabio.com/News… $ARTV #AlloNK #lupus #NKcell #NKcells #NKcelltherapy #autoimmunedisease #cancer”View original tweet ↗